HEADER    HYDROLASE                               21-OCT-20   7AQI              
TITLE     STRUCTURE OF SARS-COV-2 MAIN PROTEASE BOUND TO IFENPRODIL             
CAVEAT     7AQI    QEL A 401 HAS WRONG CHIRALITY AT ATOM C13 QEL A 401 HAS      
CAVEAT   2 7AQI    WRONG CHIRALITY AT ATOM C14                                  
COMPND    MOL_ID: 1;                                                            
COMPND   2 MOLECULE: 3C-LIKE PROTEINASE;                                        
COMPND   3 CHAIN: A;                                                            
COMPND   4 SYNONYM: 3CL-PRO,3CLP,MAIN PROTEASE,MPRO,NON-STRUCTURAL PROTEIN 5,   
COMPND   5 NSP5,SARS CORONAVIRUS MAIN PROTEINASE;                               
COMPND   6 EC: 3.4.22.69;                                                       
COMPND   7 ENGINEERED: YES                                                      
SOURCE    MOL_ID: 1;                                                            
SOURCE   2 ORGANISM_SCIENTIFIC: SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS   
SOURCE   3 2;                                                                   
SOURCE   4 ORGANISM_COMMON: 2019-NCOV, SARS-COV-2;                              
SOURCE   5 ORGANISM_TAXID: 2697049;                                             
SOURCE   6 GENE: REP, 1A-1B;                                                    
SOURCE   7 EXPRESSION_SYSTEM: ESCHERICHIA COLI;                                 
SOURCE   8 EXPRESSION_SYSTEM_TAXID: 562                                         
KEYWDS    SARS-COV-2, MAIN PROTEASE, ANTI-VIRAL, COVID-19 PANDEMIC, HYDROLASE   
EXPDTA    X-RAY DIFFRACTION                                                     
AUTHOR    F.KOUA,S.GUENTHER,P.REINKE,D.OBERTHUER,O.YEFANOV,L.GELISIO,H.GINN,    
AUTHOR   2 J.LIESKE,W.EWERT,M.DOMARACKY,W.BREHM,A.RAHMANI MASHOUR,T.A.WHITE,    
AUTHOR   3 J.KNOSKA,G.PENA ESPERANZA,A.TOLSTIKOVA,M.GROESSLER,P.FISCHER,        
AUTHOR   4 V.HENNICKE,H.FLECKENSTEIN,F.TROST,M.GALCHENKOVA,Y.GEVORKOV,C.LI,     
AUTHOR   5 S.AWEL,L.X.PAULRAJ,N.ULLAH,S.FALKE,B.ALVES FRANCA,M.SCHWINZER,       
AUTHOR   6 H.BROGNARO,N.WERNER,M.PERBANDT,H.TIDOW,B.SEYCHELL,T.BECK,S.MEIER,    
AUTHOR   7 J.J.DOYLE,H.GISELER,D.MELO,I.DUNKEL,T.J.LANE,A.PECK,S.SAOUANE,       
AUTHOR   8 J.HAKANPAEAE,J.MEYER,H.NOEI,P.GRIBBON,B.ELLINGER,M.KUZIKOV,M.WOLF,   
AUTHOR   9 L.ZHANG,C.EHRT,J.PLETZER-ZELGERT,J.WOLLENHAUPT,C.FEILER,M.WEISS,     
AUTHOR  10 E.C.SCHULZ,P.MEHRABI,B.NORTON-BAKER,C.SCHMIDT,K.LORENZEN,R.SCHUBERT, 
AUTHOR  11 H.HAN,A.CHARI,Y.FERNANDEZ GARCIA,D.TURK,R.HILGENFELD,M.RAREY,        
AUTHOR  12 A.ZALIANI,H.N.CHAPMAN,A.PEARSON,C.BETZEL,A.MEENTS                    
REVDAT   4   19-MAY-21 7AQI    1       JRNL                                     
REVDAT   3   14-APR-21 7AQI    1       COMPND SOURCE AUTHOR JRNL                
REVDAT   2   09-DEC-20 7AQI    1       JRNL   REMARK                            
REVDAT   1   02-DEC-20 7AQI    0                                                
JRNL        AUTH   S.GUNTHER,P.Y.A.REINKE,Y.FERNANDEZ-GARCIA,J.LIESKE,T.J.LANE, 
JRNL        AUTH 2 H.M.GINN,F.H.M.KOUA,C.EHRT,W.EWERT,D.OBERTHUER,O.YEFANOV,    
JRNL        AUTH 3 S.MEIER,K.LORENZEN,B.KRICHEL,J.D.KOPICKI,L.GELISIO,W.BREHM,  
JRNL        AUTH 4 I.DUNKEL,B.SEYCHELL,H.GIESELER,B.NORTON-BAKER,               
JRNL        AUTH 5 B.ESCUDERO-PEREZ,M.DOMARACKY,S.SAOUANE,A.TOLSTIKOVA,         
JRNL        AUTH 6 T.A.WHITE,A.HANLE,M.GROESSLER,H.FLECKENSTEIN,F.TROST,        
JRNL        AUTH 7 M.GALCHENKOVA,Y.GEVORKOV,C.LI,S.AWEL,A.PECK,M.BARTHELMESS,   
JRNL        AUTH 8 F.SCHLUNZEN,P.LOURDU XAVIER,N.WERNER,H.ANDALEEB,N.ULLAH,     
JRNL        AUTH 9 S.FALKE,V.SRINIVASAN,B.A.FRANCA,M.SCHWINZER,H.BROGNARO,      
JRNL        AUTH10 C.ROGERS,D.MELO,J.J.ZAITSEVA-DOYLE,J.KNOSKA,                 
JRNL        AUTH11 G.E.PENA-MURILLO,A.R.MASHHOUR,V.HENNICKE,P.FISCHER,          
JRNL        AUTH12 J.HAKANPAA,J.MEYER,P.GRIBBON,B.ELLINGER,M.KUZIKOV,M.WOLF,    
JRNL        AUTH13 A.R.BECCARI,G.BOURENKOV,D.VON STETTEN,G.POMPIDOR,I.BENTO,    
JRNL        AUTH14 S.PANNEERSELVAM,I.KARPICS,T.R.SCHNEIDER,M.M.GARCIA-ALAI,     
JRNL        AUTH15 S.NIEBLING,C.GUNTHER,C.SCHMIDT,R.SCHUBERT,H.HAN,J.BOGER,     
JRNL        AUTH16 D.C.F.MONTEIRO,L.ZHANG,X.SUN,J.PLETZER-ZELGERT,              
JRNL        AUTH17 J.WOLLENHAUPT,C.G.FEILER,M.S.WEISS,E.C.SCHULZ,P.MEHRABI,     
JRNL        AUTH18 K.KARNICAR,A.USENIK,J.LOBODA,H.TIDOW,A.CHARI,R.HILGENFELD,   
JRNL        AUTH19 C.UETRECHT,R.COX,A.ZALIANI,T.BECK,M.RAREY,S.GUNTHER,D.TURK,  
JRNL        AUTH20 W.HINRICHS,H.N.CHAPMAN,A.R.PEARSON,C.BETZEL,A.MEENTS         
JRNL        TITL   X-RAY SCREENING IDENTIFIES ACTIVE SITE AND ALLOSTERIC        
JRNL        TITL 2 INHIBITORS OF SARS-COV-2 MAIN PROTEASE.                      
JRNL        REF    SCIENCE                       V. 372   642 2021              
JRNL        REFN                   ESSN 1095-9203                               
JRNL        PMID   33811162                                                     
JRNL        DOI    10.1126/SCIENCE.ABF7945                                      
REMARK   1                                                                      
REMARK   1 REFERENCE 1                                                          
REMARK   1  AUTH   S.GUENTHER,P.Y.A.,REINKE,Y.,FERNANDEZ-GARCIA,J.,LIESKE,T.J., 
REMARK   1  AUTH 2 LANE,H.M.,GINN,F.H.M.,KOUA,C.,EHRT,W.,EWERT,D.,OBERTHUER,O., 
REMARK   1  AUTH 3 YEFANOV,S.,MEIER,K.,LORENZEN,B.,KRICHEL,J.D.,KOPICKI,L.,     
REMARK   1  AUTH 4 GELISIO,W.,BREHM,I.,DUNKEL,B.,SEYCHELL,H.,GIESELER,B.,       
REMARK   1  AUTH 5 NORTON-BAKER,B.,ESCUDERO-PEREZ,M.,DOMARACKY,S.,SAOUANE,A.,   
REMARK   1  AUTH 6 TOLSTIKOVA,T.A.,WHITE,A.,HANLE,M.,GROESSLER,H.,FLECKENSTEIN, 
REMARK   1  AUTH 7 F.,TROST,M.,GALCHENKOVA,Y.,GEVORKOV,C.,LI,S.,AWEL,A.PECK,M., 
REMARK   1  AUTH 8 BARTHELMESS,F.,SCHLUENZEN,L.X.,PAULRAJ,N.,WERNER,H.,         
REMARK   1  AUTH 9 ANDALEEB,N.,ULLAH,S.,FALKE,V.,SRINIVASAN,B.,FRANCA,M.,       
REMARK   1  AUTH10 SCHWINZER,H.,BROGNARO,C.,ROGERS,D.,MELO,J.J.,DOYLE,J.,       
REMARK   1  AUTH11 KNOSKA,G.E.,PENA MURILLO,A.,RAHMANI MASHHOUR,F.,GUICKING,V., 
REMARK   1  AUTH12 HENNICKE,P.,FISCHER,J.,HAKANPAEAE,J.,MEYER,P.,GRIBBON,B.,    
REMARK   1  AUTH13 ELLINGER,M.,KUZIKOV,M.,WOLF,G.,BURENKOV,D.,VON STETTEN,G.,   
REMARK   1  AUTH14 POMPIDOR,I.,BENTO,S.,PANNEERSELVAM,I.,KARPICS,T.R.,          
REMARK   1  AUTH15 SCHNEIDER,M.,GARCIA ALAI,S.,NIEBLING,C.,GUENTHER,C.,SCHMIDT, 
REMARK   1  AUTH16 R.,SCHUBERT,H.,HAN,J.,BOGER,D.,MONTEIRO,L.,ZHANG,X.,SUN,J.,  
REMARK   1  AUTH17 PLETZER-ZELGERT,J.,WOLLENHAUPT,C.,FEILER,M.,WEISS,E.C.,      
REMARK   1  AUTH18 SCHULZ,P.,MEHRABI,K.,KARNICAR,A.,USENIK,J.,LOBODA,H.,TIDOW,  
REMARK   1  AUTH19 A.,CHARI,R.,HILGENFELD,C.,UETRECHT,R.,COX,A.,ZALIANI,T.,     
REMARK   1  AUTH20 BECK,M.,RAREY,S.,GUENTHER,D.,TURK,W.,HINRICHS,H.N.,CHAPMAN,  
REMARK   1  AUTH21 A.,PEARSON,C.,BETZEL,A.MEENTS                                
REMARK   1  TITL   INHIBITION OF SARS-COV-2 MAIN PROTEASE BY ALLOSTERIC         
REMARK   1  TITL 2 DRUG-BINDING                                                 
REMARK   1  REF    BIORXIV                                    2020              
REMARK   1  REFN                                                                
REMARK   1  DOI    10.1101/2020.11.12.378422                                    
REMARK   2                                                                      
REMARK   2 RESOLUTION.    1.70 ANGSTROMS.                                       
REMARK   3                                                                      
REMARK   3 REFINEMENT.                                                          
REMARK   3   PROGRAM     : REFMAC 5.8                                           
REMARK   3   AUTHORS     : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER,              
REMARK   3               : NICHOLLS,WINN,LONG,VAGIN                             
REMARK   3                                                                      
REMARK   3    REFINEMENT TARGET : MAXIMUM LIKELIHOOD                            
REMARK   3                                                                      
REMARK   3  DATA USED IN REFINEMENT.                                            
REMARK   3   RESOLUTION RANGE HIGH (ANGSTROMS) : 1.70                           
REMARK   3   RESOLUTION RANGE LOW  (ANGSTROMS) : 47.81                          
REMARK   3   DATA CUTOFF            (SIGMA(F)) : 0.000                          
REMARK   3   COMPLETENESS FOR RANGE        (%) : 98.5                           
REMARK   3   NUMBER OF REFLECTIONS             : 27118                          
REMARK   3                                                                      
REMARK   3  FIT TO DATA USED IN REFINEMENT.                                     
REMARK   3   CROSS-VALIDATION METHOD          : THROUGHOUT                      
REMARK   3   FREE R VALUE TEST SET SELECTION  : RANDOM                          
REMARK   3   R VALUE     (WORKING + TEST SET) : 0.227                           
REMARK   3   R VALUE            (WORKING SET) : 0.226                           
REMARK   3   FREE R VALUE                     : 0.266                           
REMARK   3   FREE R VALUE TEST SET SIZE   (%) : 3.400                           
REMARK   3   FREE R VALUE TEST SET COUNT      : 949                             
REMARK   3                                                                      
REMARK   3  FIT IN THE HIGHEST RESOLUTION BIN.                                  
REMARK   3   TOTAL NUMBER OF BINS USED           : NULL                         
REMARK   3   BIN RESOLUTION RANGE HIGH       (A) : 1.70                         
REMARK   3   BIN RESOLUTION RANGE LOW        (A) : 1.74                         
REMARK   3   REFLECTION IN BIN     (WORKING SET) : 1945                         
REMARK   3   BIN COMPLETENESS (WORKING+TEST) (%) : 96.69                        
REMARK   3   BIN R VALUE           (WORKING SET) : NULL                         
REMARK   3   BIN FREE R VALUE SET COUNT          : 70                           
REMARK   3   BIN FREE R VALUE                    : NULL                         
REMARK   3                                                                      
REMARK   3  NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT.                    
REMARK   3   PROTEIN ATOMS            : 2367                                    
REMARK   3   NUCLEIC ACID ATOMS       : 0                                       
REMARK   3   HETEROGEN ATOMS          : 42                                      
REMARK   3   SOLVENT ATOMS            : 274                                     
REMARK   3                                                                      
REMARK   3  B VALUES.                                                           
REMARK   3   FROM WILSON PLOT           (A**2) : 15.87                          
REMARK   3   MEAN B VALUE      (OVERALL, A**2) : 23.82                          
REMARK   3   OVERALL ANISOTROPIC B VALUE.                                       
REMARK   3    B11 (A**2) : 1.85000                                              
REMARK   3    B22 (A**2) : 0.53000                                              
REMARK   3    B33 (A**2) : -1.90000                                             
REMARK   3    B12 (A**2) : 0.00000                                              
REMARK   3    B13 (A**2) : -0.59000                                             
REMARK   3    B23 (A**2) : 0.00000                                              
REMARK   3                                                                      
REMARK   3  ESTIMATED OVERALL COORDINATE ERROR.                                 
REMARK   3   ESU BASED ON R VALUE                            (A): 0.193         
REMARK   3   ESU BASED ON FREE R VALUE                       (A): 0.161         
REMARK   3   ESU BASED ON MAXIMUM LIKELIHOOD                 (A): 0.226         
REMARK   3   ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 8.558         
REMARK   3                                                                      
REMARK   3 CORRELATION COEFFICIENTS.                                            
REMARK   3   CORRELATION COEFFICIENT FO-FC      : 0.956                         
REMARK   3   CORRELATION COEFFICIENT FO-FC FREE : 0.938                         
REMARK   3                                                                      
REMARK   3  RMS DEVIATIONS FROM IDEAL VALUES        COUNT    RMS    WEIGHT      
REMARK   3   BOND LENGTHS REFINED ATOMS        (A):  NULL ;  NULL ;  NULL       
REMARK   3   BOND LENGTHS OTHERS               (A):  NULL ;  NULL ;  NULL       
REMARK   3   BOND ANGLES REFINED ATOMS   (DEGREES):  NULL ;  NULL ;  NULL       
REMARK   3   BOND ANGLES OTHERS          (DEGREES):  NULL ;  NULL ;  NULL       
REMARK   3   TORSION ANGLES, PERIOD 1    (DEGREES):  NULL ;  NULL ;  NULL       
REMARK   3   TORSION ANGLES, PERIOD 2    (DEGREES):  NULL ;  NULL ;  NULL       
REMARK   3   TORSION ANGLES, PERIOD 3    (DEGREES):  NULL ;  NULL ;  NULL       
REMARK   3   TORSION ANGLES, PERIOD 4    (DEGREES):  NULL ;  NULL ;  NULL       
REMARK   3   CHIRAL-CENTER RESTRAINTS       (A**3):  NULL ;  NULL ;  NULL       
REMARK   3   GENERAL PLANES REFINED ATOMS      (A):  NULL ;  NULL ;  NULL       
REMARK   3   GENERAL PLANES OTHERS             (A):  NULL ;  NULL ;  NULL       
REMARK   3   NON-BONDED CONTACTS REFINED ATOMS (A):  NULL ;  NULL ;  NULL       
REMARK   3   NON-BONDED CONTACTS OTHERS        (A):  NULL ;  NULL ;  NULL       
REMARK   3   NON-BONDED TORSION REFINED ATOMS  (A):  NULL ;  NULL ;  NULL       
REMARK   3   NON-BONDED TORSION OTHERS         (A):  NULL ;  NULL ;  NULL       
REMARK   3   H-BOND (X...Y) REFINED ATOMS      (A):  NULL ;  NULL ;  NULL       
REMARK   3   H-BOND (X...Y) OTHERS             (A):  NULL ;  NULL ;  NULL       
REMARK   3   POTENTIAL METAL-ION REFINED ATOMS (A):  NULL ;  NULL ;  NULL       
REMARK   3   POTENTIAL METAL-ION OTHERS        (A):  NULL ;  NULL ;  NULL       
REMARK   3   SYMMETRY VDW REFINED ATOMS        (A):  NULL ;  NULL ;  NULL       
REMARK   3   SYMMETRY VDW OTHERS               (A):  NULL ;  NULL ;  NULL       
REMARK   3   SYMMETRY H-BOND REFINED ATOMS     (A):  NULL ;  NULL ;  NULL       
REMARK   3   SYMMETRY H-BOND OTHERS            (A):  NULL ;  NULL ;  NULL       
REMARK   3   SYMMETRY METAL-ION REFINED ATOMS  (A):  NULL ;  NULL ;  NULL       
REMARK   3   SYMMETRY METAL-ION OTHERS         (A):  NULL ;  NULL ;  NULL       
REMARK   3                                                                      
REMARK   3  ISOTROPIC THERMAL FACTOR RESTRAINTS.     COUNT   RMS    WEIGHT      
REMARK   3   MAIN-CHAIN BOND REFINED ATOMS  (A**2):  NULL ;  NULL ;  NULL       
REMARK   3   MAIN-CHAIN BOND OTHER ATOMS    (A**2):  NULL ;  NULL ;  NULL       
REMARK   3   MAIN-CHAIN ANGLE REFINED ATOMS (A**2):  NULL ;  NULL ;  NULL       
REMARK   3   MAIN-CHAIN ANGLE OTHER ATOMS   (A**2):  NULL ;  NULL ;  NULL       
REMARK   3   SIDE-CHAIN BOND REFINED ATOMS  (A**2):  NULL ;  NULL ;  NULL       
REMARK   3   SIDE-CHAIN BOND OTHER ATOMS    (A**2):  NULL ;  NULL ;  NULL       
REMARK   3   SIDE-CHAIN ANGLE REFINED ATOMS (A**2):  NULL ;  NULL ;  NULL       
REMARK   3   SIDE-CHAIN ANGLE OTHER ATOMS   (A**2):  NULL ;  NULL ;  NULL       
REMARK   3   LONG RANGE B REFINED ATOMS     (A**2):  NULL ;  NULL ;  NULL       
REMARK   3   LONG RANGE B OTHER ATOMS       (A**2):  NULL ;  NULL ;  NULL       
REMARK   3                                                                      
REMARK   3 ANISOTROPIC THERMAL FACTOR RESTRAINTS.    COUNT   RMS   WEIGHT       
REMARK   3   RIGID-BOND RESTRAINTS          (A**2):  NULL ;  NULL ;  NULL       
REMARK   3   SPHERICITY; FREE ATOMS         (A**2):  NULL ;  NULL ;  NULL       
REMARK   3   SPHERICITY; BONDED ATOMS       (A**2):  NULL ;  NULL ;  NULL       
REMARK   3                                                                      
REMARK   3  NCS RESTRAINTS STATISTICS                                           
REMARK   3   NUMBER OF DIFFERENT NCS GROUPS : NULL                              
REMARK   3                                                                      
REMARK   3  TLS DETAILS                                                         
REMARK   3   NUMBER OF TLS GROUPS  : NULL                                       
REMARK   3                                                                      
REMARK   3  BULK SOLVENT MODELLING.                                             
REMARK   3   METHOD USED : MASK                                                 
REMARK   3   PARAMETERS FOR MASK CALCULATION                                    
REMARK   3   VDW PROBE RADIUS   : 1.20                                          
REMARK   3   ION PROBE RADIUS   : 0.80                                          
REMARK   3   SHRINKAGE RADIUS   : 0.80                                          
REMARK   3                                                                      
REMARK   3  OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING   
REMARK   3  POSITIONS U VALUES : REFINED INDIVIDUALLY                           
REMARK   4                                                                      
REMARK   4 7AQI COMPLIES WITH FORMAT V. 3.30, 13-JUL-11                         
REMARK 100                                                                      
REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 21-OCT-20.                  
REMARK 100 THE DEPOSITION ID IS D_1292111907.                                   
REMARK 200                                                                      
REMARK 200 EXPERIMENTAL DETAILS                                                 
REMARK 200  EXPERIMENT TYPE                : X-RAY DIFFRACTION                  
REMARK 200  DATE OF DATA COLLECTION        : 06-APR-20                          
REMARK 200  TEMPERATURE           (KELVIN) : 100                                
REMARK 200  PH                             : 7.5                                
REMARK 200  NUMBER OF CRYSTALS USED        : 1                                  
REMARK 200                                                                      
REMARK 200  SYNCHROTRON              (Y/N) : Y                                  
REMARK 200  RADIATION SOURCE               : PETRA III, DESY                    
REMARK 200  BEAMLINE                       : P11                                
REMARK 200  X-RAY GENERATOR MODEL          : NULL                               
REMARK 200  MONOCHROMATIC OR LAUE    (M/L) : M                                  
REMARK 200  WAVELENGTH OR RANGE        (A) : 1.0332                             
REMARK 200  MONOCHROMATOR                  : NULL                               
REMARK 200  OPTICS                         : NULL                               
REMARK 200                                                                      
REMARK 200  DETECTOR TYPE                  : PIXEL                              
REMARK 200  DETECTOR MANUFACTURER          : DECTRIS PILATUS 6M                 
REMARK 200  INTENSITY-INTEGRATION SOFTWARE : XDS                                
REMARK 200  DATA SCALING SOFTWARE          : XSCALE                             
REMARK 200                                                                      
REMARK 200  NUMBER OF UNIQUE REFLECTIONS   : 28082                              
REMARK 200  RESOLUTION RANGE HIGH      (A) : 1.700                              
REMARK 200  RESOLUTION RANGE LOW       (A) : 47.810                             
REMARK 200  REJECTION CRITERIA  (SIGMA(I)) : NULL                               
REMARK 200                                                                      
REMARK 200 OVERALL.                                                             
REMARK 200  COMPLETENESS FOR RANGE     (%) : 98.5                               
REMARK 200  DATA REDUNDANCY                : 3.600                              
REMARK 200  R MERGE                    (I) : NULL                               
REMARK 200  R SYM                      (I) : NULL                               
REMARK 200  <I/SIGMA(I)> FOR THE DATA SET  : 4.3500                             
REMARK 200                                                                      
REMARK 200 IN THE HIGHEST RESOLUTION SHELL.                                     
REMARK 200  HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.70                     
REMARK 200  HIGHEST RESOLUTION SHELL, RANGE LOW  (A) : 1.76                     
REMARK 200  COMPLETENESS FOR SHELL     (%) : 96.6                               
REMARK 200  DATA REDUNDANCY IN SHELL       : 3.70                               
REMARK 200  R MERGE FOR SHELL          (I) : 0.84740                            
REMARK 200  R SYM FOR SHELL            (I) : NULL                               
REMARK 200  <I/SIGMA(I)> FOR SHELL         : 0.950                              
REMARK 200                                                                      
REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH                              
REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT        
REMARK 200 SOFTWARE USED: PHASER                                                
REMARK 200 STARTING MODEL: 6YB7                                                 
REMARK 200                                                                      
REMARK 200 REMARK: NULL                                                         
REMARK 280                                                                      
REMARK 280 CRYSTAL                                                              
REMARK 280 SOLVENT CONTENT, VS   (%): 36.27                                     
REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 1.93                     
REMARK 280                                                                      
REMARK 280 CRYSTALLIZATION CONDITIONS: CO-CRYSTALLIZATION WITH THE COMPOUNDS    
REMARK 280  WAS ACHIEVED BY EQULIBRATING A 6.25 MG/ML PROTEIN SOLUTION IN 20    
REMARK 280  MM HEPES BUFFER (PH 7.8) CONTAINING 1 MM DTT, 1MM EDTA, AND 150     
REMARK 280  MM NACL AGAINST A RESERVOIR SOLUTION OF 100 MM MIB BUFFER (2:3:3    
REMARK 280  MOLAR RATIO OF MALONIC ACID, IMIDAZOLE, AND BORIC ACID), PH 7.5,    
REMARK 280  CONTAINING 25% V/V PEG 1500 AND 5% V/V DMSO. PRIOR TO               
REMARK 280  CRYSTALLIZATION COMPOUND SOLUTIONS IN DMSO WERE DRIED ONTO THE      
REMARK 280  WELLS OF SWISSCI 96-WELL PLATES. TO ACHIEVE REPRODUCIBLE CRYSTAL    
REMARK 280  GROWTH SEEDING WAS USED. CRYSTALS APPEARED WITHIN A FEW HOURS       
REMARK 280  AND REACHED THEIR FINAL SIZE AFTER 2 -3 DAYS., COUNTER-DIFFUSION,   
REMARK 280  TEMPERATURE 291K                                                    
REMARK 290                                                                      
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY                                            
REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1                          
REMARK 290                                                                      
REMARK 290      SYMOP   SYMMETRY                                                
REMARK 290     NNNMMM   OPERATOR                                                
REMARK 290       1555   X,Y,Z                                                   
REMARK 290       2555   -X,Y,-Z                                                 
REMARK 290       3555   X+1/2,Y+1/2,Z                                           
REMARK 290       4555   -X+1/2,Y+1/2,-Z                                         
REMARK 290                                                                      
REMARK 290     WHERE NNN -> OPERATOR NUMBER                                     
REMARK 290           MMM -> TRANSLATION VECTOR                                  
REMARK 290                                                                      
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS                            
REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM             
REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY                
REMARK 290 RELATED MOLECULES.                                                   
REMARK 290   SMTRY1   1  1.000000  0.000000  0.000000        0.00000            
REMARK 290   SMTRY2   1  0.000000  1.000000  0.000000        0.00000            
REMARK 290   SMTRY3   1  0.000000  0.000000  1.000000        0.00000            
REMARK 290   SMTRY1   2 -1.000000  0.000000  0.000000        0.00000            
REMARK 290   SMTRY2   2  0.000000  1.000000  0.000000        0.00000            
REMARK 290   SMTRY3   2  0.000000  0.000000 -1.000000        0.00000            
REMARK 290   SMTRY1   3  1.000000  0.000000  0.000000       56.59250            
REMARK 290   SMTRY2   3  0.000000  1.000000  0.000000       26.49350            
REMARK 290   SMTRY3   3  0.000000  0.000000  1.000000        0.00000            
REMARK 290   SMTRY1   4 -1.000000  0.000000  0.000000       56.59250            
REMARK 290   SMTRY2   4  0.000000  1.000000  0.000000       26.49350            
REMARK 290   SMTRY3   4  0.000000  0.000000 -1.000000        0.00000            
REMARK 290                                                                      
REMARK 290 REMARK: NULL                                                         
REMARK 300                                                                      
REMARK 300 BIOMOLECULE: 1                                                       
REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM                
REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN                  
REMARK 300 THIS ENTRY.  THE REMARK MAY ALSO  PROVIDE INFORMATION ON             
REMARK 300 BURIED SURFACE AREA.                                                 
REMARK 350                                                                      
REMARK 350 COORDINATES FOR A COMPLETE MULTIMER  REPRESENTING THE KNOWN          
REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE  OF THE               
REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT  TRANSFORMATIONS         
REMARK 350 GIVEN BELOW.  BOTH NON-CRYSTALLOGRAPHIC  AND                         
REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN.                               
REMARK 350                                                                      
REMARK 350 BIOMOLECULE: 1                                                       
REMARK 350 SOFTWARE USED: UCSF CHIMERA 1.16_b42360.                             
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A                                     
REMARK 350   BIOMT1   1  1.000000  0.000000 -0.000000        0.00000            
REMARK 350   BIOMT2   1 -0.000000  1.000000  0.000000        0.00000            
REMARK 350   BIOMT3   1  0.000000  0.000000  1.000000        0.00000            
REMARK 350   BIOMT1   2 -0.999997 -0.002461  0.000001       -0.09752            
REMARK 350   BIOMT2   2 -0.002461  0.999997 -0.000893       -0.00010            
REMARK 350   BIOMT3   2  0.000001 -0.000893 -1.000000        0.04652            
REMARK 375                                                                      
REMARK 375 SPECIAL POSITION                                                     
REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS            
REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL          
REMARK 375 POSITIONS.                                                           
REMARK 375                                                                      
REMARK 375 ATOM RES CSSEQI                                                      
REMARK 375      HOH A 739  LIES ON A SPECIAL POSITION.                          
REMARK 375      HOH A 742  LIES ON A SPECIAL POSITION.                          
REMARK 500                                                                      
REMARK 500 GEOMETRY AND STEREOCHEMISTRY                                         
REMARK 500 SUBTOPIC: TORSION ANGLES                                             
REMARK 500                                                                      
REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS:            
REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;               
REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).                             
REMARK 500                                                                      
REMARK 500 STANDARD TABLE:                                                      
REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2)                    
REMARK 500                                                                      
REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI-           
REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400            
REMARK 500                                                                      
REMARK 500  M RES CSSEQI        PSI       PHI                                   
REMARK 500    ASP A  33     -133.75     56.12                                   
REMARK 500    ASP A  33     -133.75     56.12                                   
REMARK 500    ASN A  84     -117.53     53.32                                   
REMARK 500    ASN A  84     -117.53     53.32                                   
REMARK 500    TYR A 154      -97.50     59.07                                   
REMARK 500    TYR A 154      -98.13     58.12                                   
REMARK 500    HIS A 164      -52.66   -125.82                                   
REMARK 500    HIS A 164      -51.12   -124.55                                   
REMARK 500    THR A 304     -160.27   -124.27                                   
REMARK 500    THR A 304     -160.24   -124.27                                   
REMARK 500                                                                      
REMARK 500 REMARK: NULL                                                         
REMARK 525                                                                      
REMARK 525 SOLVENT                                                              
REMARK 525                                                                      
REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT                    
REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST                  
REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT                 
REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE                       
REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER;                             
REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE                  
REMARK 525 NUMBER; I=INSERTION CODE):                                           
REMARK 525                                                                      
REMARK 525  M RES CSSEQI                                                        
REMARK 525    HOH A 773        DISTANCE =  6.53 ANGSTROMS                       
REMARK 525    HOH A 774        DISTANCE =  6.72 ANGSTROMS                       
REMARK 800                                                                      
REMARK 800 SITE                                                                 
REMARK 800 SITE_IDENTIFIER: AC1                                                 
REMARK 800 EVIDENCE_CODE: SOFTWARE                                              
REMARK 800 SITE_DESCRIPTION: binding site for residue QEL A 401                 
REMARK 800                                                                      
REMARK 800 SITE_IDENTIFIER: AC2                                                 
REMARK 800 EVIDENCE_CODE: SOFTWARE                                              
REMARK 800 SITE_DESCRIPTION: binding site for residue DMS A 402                 
REMARK 800                                                                      
REMARK 800 SITE_IDENTIFIER: AC3                                                 
REMARK 800 EVIDENCE_CODE: SOFTWARE                                              
REMARK 800 SITE_DESCRIPTION: binding site for residue DMS A 403                 
REMARK 800                                                                      
REMARK 800 SITE_IDENTIFIER: AC4                                                 
REMARK 800 EVIDENCE_CODE: SOFTWARE                                              
REMARK 800 SITE_DESCRIPTION: binding site for residue IMD A 404                 
REMARK 800                                                                      
REMARK 800 SITE_IDENTIFIER: AC5                                                 
REMARK 800 EVIDENCE_CODE: SOFTWARE                                              
REMARK 800 SITE_DESCRIPTION: binding site for residue IMD A 405                 
DBREF  7AQI A    1   306  UNP    P0DTD1   R1AB_SARS2    3264   3569             
SEQRES   1 A  306  SER GLY PHE ARG LYS MET ALA PHE PRO SER GLY LYS VAL          
SEQRES   2 A  306  GLU GLY CYS MET VAL GLN VAL THR CYS GLY THR THR THR          
SEQRES   3 A  306  LEU ASN GLY LEU TRP LEU ASP ASP VAL VAL TYR CYS PRO          
SEQRES   4 A  306  ARG HIS VAL ILE CYS THR SER GLU ASP MET LEU ASN PRO          
SEQRES   5 A  306  ASN TYR GLU ASP LEU LEU ILE ARG LYS SER ASN HIS ASN          
SEQRES   6 A  306  PHE LEU VAL GLN ALA GLY ASN VAL GLN LEU ARG VAL ILE          
SEQRES   7 A  306  GLY HIS SER MET GLN ASN CYS VAL LEU LYS LEU LYS VAL          
SEQRES   8 A  306  ASP THR ALA ASN PRO LYS THR PRO LYS TYR LYS PHE VAL          
SEQRES   9 A  306  ARG ILE GLN PRO GLY GLN THR PHE SER VAL LEU ALA CYS          
SEQRES  10 A  306  TYR ASN GLY SER PRO SER GLY VAL TYR GLN CYS ALA MET          
SEQRES  11 A  306  ARG PRO ASN PHE THR ILE LYS GLY SER PHE LEU ASN GLY          
SEQRES  12 A  306  SER CYS GLY SER VAL GLY PHE ASN ILE ASP TYR ASP CYS          
SEQRES  13 A  306  VAL SER PHE CYS TYR MET HIS HIS MET GLU LEU PRO THR          
SEQRES  14 A  306  GLY VAL HIS ALA GLY THR ASP LEU GLU GLY ASN PHE TYR          
SEQRES  15 A  306  GLY PRO PHE VAL ASP ARG GLN THR ALA GLN ALA ALA GLY          
SEQRES  16 A  306  THR ASP THR THR ILE THR VAL ASN VAL LEU ALA TRP LEU          
SEQRES  17 A  306  TYR ALA ALA VAL ILE ASN GLY ASP ARG TRP PHE LEU ASN          
SEQRES  18 A  306  ARG PHE THR THR THR LEU ASN ASP PHE ASN LEU VAL ALA          
SEQRES  19 A  306  MET LYS TYR ASN TYR GLU PRO LEU THR GLN ASP HIS VAL          
SEQRES  20 A  306  ASP ILE LEU GLY PRO LEU SER ALA GLN THR GLY ILE ALA          
SEQRES  21 A  306  VAL LEU ASP MET CYS ALA SER LEU LYS GLU LEU LEU GLN          
SEQRES  22 A  306  ASN GLY MET ASN GLY ARG THR ILE LEU GLY SER ALA LEU          
SEQRES  23 A  306  LEU GLU ASP GLU PHE THR PRO PHE ASP VAL VAL ARG GLN          
SEQRES  24 A  306  CYS SER GLY VAL THR PHE GLN                                  
HET    QEL  A 401      24                                                       
HET    DMS  A 402       4                                                       
HET    DMS  A 403       4                                                       
HET    IMD  A 404       5                                                       
HET    IMD  A 405       5                                                       
HETNAM     QEL 4-[(1R,2S)-2-(4-BENZYLPIPERIDIN-1-YL)-1-                         
HETNAM   2 QEL  HYDROXYPROPYL]PHENOL                                            
HETNAM     DMS DIMETHYL SULFOXIDE                                               
HETNAM     IMD IMIDAZOLE                                                        
HETSYN     QEL IFENPRODIL                                                       
FORMUL   2  QEL    C21 H27 N O2                                                 
FORMUL   3  DMS    2(C2 H6 O S)                                                 
FORMUL   5  IMD    2(C3 H5 N2 1+)                                               
FORMUL   7  HOH   *274(H2 O)                                                    
SITE     1 AC1  6 LEU A 253  GLN A 256  VAL A 297  CYS A 300                    
SITE     2 AC1  6 SER A 301  HOH A 578                                          
SITE     1 AC2  4 LEU A 141  ASN A 142  SER A 144  HIS A 163                    
SITE     1 AC3  5 ARG A  76  ARG A 222  PHE A 223  HOH A 536                    
SITE     2 AC3  5 HOH A 631                                                     
SITE     1 AC4  4 MET A   6  ALA A   7  SER A 123  ARG A 298                    
SITE     1 AC5  6 PRO A  96  LYS A  97  THR A  98  GLN A 273                    
SITE     2 AC5  6 ASN A 274  HOH A 550                                          
CRYST1  113.185   52.987   44.688  90.00 103.02  90.00 C 1 2 1       4          
ORIGX1      1.000000  0.000000  0.000000        0.00000                         
ORIGX2      0.000000  1.000000  0.000000        0.00000                         
ORIGX3      0.000000  0.000000  1.000000        0.00000                         
SCALE1      0.008835  0.000000  0.002043        0.00000                         
SCALE2      0.000000  0.018873  0.000000        0.00000                         
SCALE3      0.000000  0.000000  0.022968        0.00000                         
HETATM    1  C1 BQEL A 401      -1.782   4.591 -25.252  0.50 22.32           C
HETATM    2  N1 BQEL A 401       5.205   3.121 -21.783  0.50 27.85           N
HETATM    3  O1 BQEL A 401       7.332   1.505 -20.848  0.50 47.58           O
HETATM    4  C2 BQEL A 401      10.597   3.359 -19.488  0.50 45.04           C
HETATM    5  O2 BQEL A 401      11.683   4.734 -17.829  0.50 42.82           O
HETATM    6  C3 BQEL A 401       9.363   4.368 -17.678  0.50 44.42           C
HETATM    7  C4 BQEL A 401       0.670   3.240 -24.952  0.50 24.87           C
HETATM    8  C5 BQEL A 401      -0.495   2.749 -24.369  0.50 23.91           C
HETATM    9  C6 BQEL A 401      -1.707   3.412 -24.519  0.50 23.01           C
HETATM   10  C7 BQEL A 401       1.980   2.523 -24.786  0.50 26.67           C
HETATM   11  C8 BQEL A 401       2.747   2.799 -23.487  0.50 27.54           C
HETATM   12  C9 BQEL A 401       3.648   4.035 -23.559  0.50 27.80           C
HETATM   13  C01BQEL A 401      -0.631   5.093 -25.832  0.50 23.16           C
HETATM   14  C02BQEL A 401       0.583   4.429 -25.685  0.50 23.71           C
HETATM   15  C10BQEL A 401       4.421   4.309 -22.261  0.50 27.23           C
HETATM   16  C11BQEL A 401       4.305   1.938 -21.716  0.50 30.32           C
HETATM   17  C12BQEL A 401       3.657   1.667 -23.062  0.50 28.09           C
HETATM   18  C13BQEL A 401       5.726   3.393 -20.392  0.50 42.35           C
HETATM   19  C14BQEL A 401       6.888   2.369 -19.852  0.50 45.40           C
HETATM   20  C15BQEL A 401       8.192   3.000 -19.328  0.50 43.07           C
HETATM   21  C16BQEL A 401       9.417   2.794 -19.966  0.50 43.73           C
HETATM   22  C18BQEL A 401      10.562   4.147 -18.346  0.50 44.40           C
HETATM   23  C19BQEL A 401       8.201   3.784 -18.165  0.50 43.78           C
HETATM   24  C24BQEL A 401       6.015   4.898 -20.292  0.50 39.02           C
HETATM   25  HC BQEL A 401      -2.724   5.106 -25.366  0.50  0.00           H
HETATM   26  HN BQEL A 401       5.974   2.937 -22.412  0.50  0.00           H
HETATM   27  HC1BQEL A 401      11.531   3.185 -20.002  0.50  0.00           H
HETATM   28  HC2BQEL A 401       9.335   4.985 -16.792  0.50  0.00           H
HETATM   29  HC3BQEL A 401      -0.456   1.838 -23.791  0.50  0.00           H
HETATM   30  HC4BQEL A 401      -2.598   3.008 -24.063  0.50  0.00           H
HETATM   31  HC5BQEL A 401       1.780   1.452 -24.832  0.50  0.00           H
HETATM   32  HC6BQEL A 401       2.623   2.787 -25.625  0.50  0.00           H
HETATM   33  HC7BQEL A 401       2.017   2.960 -22.693  0.50  0.00           H
HETATM   34  HC8BQEL A 401       3.026   4.903 -23.778  0.50  0.00           H
HETATM   35  HC9BQEL A 401       4.363   3.901 -24.371  0.50  0.00           H
HETATM   36 HC10BQEL A 401      -0.675   6.008 -26.404  0.50  0.00           H
HETATM   37 HC11BQEL A 401       1.471   4.837 -26.143  0.50  0.00           H
HETATM   38 HC12BQEL A 401       5.112   5.134 -22.435  0.50  0.00           H
HETATM   39 HC13BQEL A 401       3.714   4.600 -21.484  0.50  0.00           H
HETATM   40 HC14BQEL A 401       4.886   1.065 -21.418  0.50  0.00           H
HETATM   41 HC15BQEL A 401       3.527   2.121 -20.974  0.50  0.00           H
HETATM   42 HC16BQEL A 401       3.071   0.750 -22.994  0.50  0.00           H
HETATM   43 HC17BQEL A 401       4.437   1.536 -23.813  0.50  0.00           H
HETATM   44 HC18BQEL A 401       4.874   3.225 -19.734  0.50  0.00           H
HETATM   45 HC19BQEL A 401       6.460   1.767 -19.050  0.50  0.00           H
HETATM   46 HC20BQEL A 401       9.450   2.180 -20.854  0.50  0.00           H
HETATM   47 HC21BQEL A 401       7.274   3.940 -17.632  0.50  0.00           H
HETATM   48  HO BQEL A 401      11.624   5.686 -17.935  0.50  0.00           H
HETATM   49 HC22BQEL A 401       6.686   5.084 -19.453  0.50  0.00           H
HETATM   50 HC23BQEL A 401       5.081   5.437 -20.137  0.50  0.00           H
HETATM   51 HC24BQEL A 401       6.484   5.240 -21.215  0.50  0.00           H
HETATM   52  HO1BQEL A 401       7.740   2.013 -21.554  0.50  0.00           H
CONECT   13    1   14   36
CONECT   14    7   13   37
CONECT    1   25    9   13
CONECT   15    2   12   38   39
CONECT   16    2   17   40   41
CONECT   17   11   16   42   43
CONECT   18    2   19   24   44
CONECT   19    3   18   20   45
CONECT   20   19   21   23
CONECT   21    4   20   46
CONECT   22    4    5    6
CONECT   23    6   20   47
CONECT    4   27   21   22
CONECT   24   18   50   51   49
CONECT    6   22   23   28
CONECT    7    8   10   14
CONECT    8    7    9   29
CONECT    9    1    8   30
CONECT   10    7   11   31   32
CONECT   11   10   12   17   33
CONECT   12   11   15   35   34
CONECT   25    1
CONECT   27    4
CONECT   36   13
CONECT   37   14
CONECT   38   15
CONECT   39   15
CONECT   40   16
CONECT   41   16
CONECT   42   17
CONECT   43   17
CONECT   44   18
CONECT   45   19
CONECT   28    6
CONECT   46   21
CONECT   47   23
CONECT   49   24
CONECT   50   24
CONECT   51   24
CONECT   29    8
CONECT   30    9
CONECT   31   10
CONECT   32   10
CONECT   33   11
CONECT   34   12
CONECT   35   12
CONECT   26    2
CONECT   48    5
CONECT   52    3
CONECT    2   26   15   16   18
CONECT    3   19   52
CONECT    5   22   48
END
